At a glance
- Originator Banyu
- Class Antineoplastics; Lactones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Feb 2001 No-Development-Reported for Cancer in Japan (unspecified route)
- 05 Nov 1998 Preclinical development for Cancer in Japan (unspecified route)